118 related articles for article (PubMed ID: 25550853)
1. Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma.
Yu Y; Sun L; Ren N; Li Y; Rong L; Zhao G
Int J Clin Exp Pathol; 2014; 7(11):8071-6. PubMed ID: 25550853
[TBL] [Abstract][Full Text] [Related]
2. FBX8 Acts as an Invasion and Metastasis Suppressor and Correlates with Poor Survival in Hepatocellular Carcinoma.
Wang F; Qiao Y; Yu J; Ren X; Wang J; Ding Y; Zhang X; Ma W; Ding Y; Liang L
PLoS One; 2013; 8(6):e65495. PubMed ID: 23826080
[TBL] [Abstract][Full Text] [Related]
3. FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma.
Wang FF; Zhang XJ; Yan YR; Zhu XH; Yu J; Ding Y; Hu JL; Zhou WJ; Zeng ZC; Liao WT; Ding YQ; Liang L
Cancer Lett; 2017 Mar; 388():85-95. PubMed ID: 27916606
[TBL] [Abstract][Full Text] [Related]
4. Significance of FBX8 in progression of gastric cancer.
Wu P; Wang F; Wang Y; Men H; Zhu X; He G; Ma W; Xin S; Wu J; Liao W; Ding Y; He M; Liang L
Exp Mol Pathol; 2015 Jun; 98(3):360-6. PubMed ID: 25801334
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
6. FBX8 degrades GSTP1 through ubiquitination to suppress colorectal cancer progression.
FeiFei W; HongHai X; YongRong Y; PingXiang W; JianHua W; XiaoHui Z; JiaoYing L; JingBo S; Kun Z; XiaoLi R; Lu Q; XiaoLiang L; ZhiQiang C; Na T; WenTing L; YanQing D; Li L
Cell Death Dis; 2019 Apr; 10(5):351. PubMed ID: 31024008
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.
Yang Y; Zhang C; Li L; Gao Y; Luo X; Zhang Y; Liu W; Fei Z
World J Surg Oncol; 2012 Aug; 10():169. PubMed ID: 22913315
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival.
Chen Y; Li ZH; Liu X; Liu GX; Yang HM; Wu PF
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6596-6601. PubMed ID: 31378901
[TBL] [Abstract][Full Text] [Related]
12. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
13. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas.
Luo Q; Que T; Luo H; Meng Y; Chen X; Huang H; Hu R; Luo K; Zheng C; Yan P; Gong J; Fu H; Liu J; Tang Q; Huang G
Pathol Res Pract; 2020 Mar; 216(3):152828. PubMed ID: 32008867
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic role of SOX9 expression in human malignant glioma.
Wang L; He S; Yuan J; Mao X; Cao Y; Zong J; Tu Y; Zhang Y
Med Oncol; 2012 Dec; 29(5):3484-90. PubMed ID: 22714060
[TBL] [Abstract][Full Text] [Related]
16. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
18. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.
Guo YF; Wang XB; Tian XY; Li Y; Li B; Huang Q; Zhang M; Li Z
World J Surg Oncol; 2012 Jun; 10():128. PubMed ID: 22741575
[TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
